OA09136A - Nouveau dérivé de la dihydro-1,4 pyridine denommé (-) {[(amino-2 éthoxy)-2 éthoxy] méthy1}-2 (dichloro-2,3 phényl)-4 éthoxycarbonyl-3 methoxycarbonyl-5 méthyl-6 dihydro-1,4 pyridine, son procédé de préparation et les compositions pharmaceutiques qui le contiennent. - Google Patents

Nouveau dérivé de la dihydro-1,4 pyridine denommé (-) {[(amino-2 éthoxy)-2 éthoxy] méthy1}-2 (dichloro-2,3 phényl)-4 éthoxycarbonyl-3 methoxycarbonyl-5 méthyl-6 dihydro-1,4 pyridine, son procédé de préparation et les compositions pharmaceutiques qui le contiennent.

Info

Publication number
OA09136A
OA09136A OA59656A OA59656A OA09136A OA 09136 A OA09136 A OA 09136A OA 59656 A OA59656 A OA 59656A OA 59656 A OA59656 A OA 59656A OA 09136 A OA09136 A OA 09136A
Authority
OA
OAPI
Prior art keywords
methyl
pyridine
dihydro
aminoethoxy
dichlorophenyl
Prior art date
Application number
OA59656A
Other languages
English (en)
French (fr)
Inventor
Peglion Jean-Louis
Gargouil Yves-Michel
Vilaine Jean-Paul
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of OA09136A publication Critical patent/OA09136A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
OA59656A 1989-07-04 1989-10-02 Nouveau dérivé de la dihydro-1,4 pyridine denommé (-) {[(amino-2 éthoxy)-2 éthoxy] méthy1}-2 (dichloro-2,3 phényl)-4 éthoxycarbonyl-3 methoxycarbonyl-5 méthyl-6 dihydro-1,4 pyridine, son procédé de préparation et les compositions pharmaceutiques qui le contiennent. OA09136A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8908920A FR2649395B1 (fr) 1989-07-04 1989-07-04 Nouveau derive de la dihydro-1,4 pyridine denomme (-) Ÿi1Ÿ(((amino-2 ethoxy)-2 ethoxy) methylŸi1Ÿ) -2 (dichloro-2,3 phenyl)-4 ethoxycarbonyl-3 methoxycarbonyl-5 methyl-6 dihydro-1,4 pyridine, son procede de preparation et les compositions qui le contiennent

Publications (1)

Publication Number Publication Date
OA09136A true OA09136A (fr) 1991-10-31

Family

ID=9383413

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59656A OA09136A (fr) 1989-07-04 1989-10-02 Nouveau dérivé de la dihydro-1,4 pyridine denommé (-) {[(amino-2 éthoxy)-2 éthoxy] méthy1}-2 (dichloro-2,3 phényl)-4 éthoxycarbonyl-3 methoxycarbonyl-5 méthyl-6 dihydro-1,4 pyridine, son procédé de préparation et les compositions pharmaceutiques qui le contiennent.

Country Status (14)

Country Link
EP (1) EP0406502B1 (ja)
JP (1) JPH0720934B2 (ja)
AT (1) ATE122340T1 (ja)
AU (1) AU619049B2 (ja)
CA (1) CA1327582C (ja)
DE (1) DE68922605T2 (ja)
DK (1) DK478989A (ja)
ES (1) ES2074472T3 (ja)
FR (1) FR2649395B1 (ja)
IE (1) IE67059B1 (ja)
NZ (1) NZ230854A (ja)
OA (1) OA09136A (ja)
PT (1) PT91869B (ja)
ZA (1) ZA897349B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652083B1 (fr) * 1989-09-20 1992-01-24 Ador Cie Nouveau procede de separation d'isomeres optiques des derives de la dihydro-1,4 pyridine.
FR2686879B1 (fr) * 1992-02-05 1994-03-18 Adir Cie Nouveaux composes de 1,4-dihydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant.
DE4444864A1 (de) * 1994-12-16 1996-06-20 Bayer Ag Verwendung von 5-Acyl-1,4-dihydropyridinen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
FR2602231B1 (fr) * 1986-08-04 1988-10-28 Adir Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
ES2074472T3 (es) 1995-09-16
DK478989A (da) 1991-01-05
JPH0720934B2 (ja) 1995-03-08
DE68922605T2 (de) 1996-01-04
ATE122340T1 (de) 1995-05-15
EP0406502A1 (fr) 1991-01-09
JPH0344371A (ja) 1991-02-26
DE68922605D1 (de) 1995-06-14
ZA897349B (en) 1990-09-26
FR2649395B1 (fr) 1992-11-06
IE893103A1 (en) 1991-01-16
CA1327582C (fr) 1994-03-08
DK478989D0 (da) 1989-09-28
PT91869A (pt) 1991-03-20
AU4239089A (en) 1991-01-10
EP0406502B1 (fr) 1995-05-10
IE67059B1 (en) 1996-02-21
NZ230854A (en) 1991-02-26
FR2649395A1 (fr) 1991-01-11
AU619049B2 (en) 1992-01-16
PT91869B (pt) 1995-07-18

Similar Documents

Publication Publication Date Title
ATE185807T1 (de) Thiazolylbenzofuranderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten
OA09378A (fr) "Nouveaux dérivés de la pipéridine, de la tétrahydropyridine et de la pyrrolidine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent".
ATE50256T1 (de) Hypoglycemische thiazolidinedione.
ATE126216T1 (de) Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
BR8704582A (pt) Processo para preparar derivados de piridinacarboxamida
NO913136L (no) Fremgangsmaate for fremstilling av et preparat for oeyedraaper
KR910018025A (ko) 약제로서 n-알킬화 1,4-디히드로피리딘디카르복실산 에스테르의 용도, 신규 화합물-및 그의 제조방법
ES2056860T3 (es) Derivados de n-((2-oxopirrolidin-1-il)-acetil)piperazina y medicamento contra la demencia senil.
IT8720260A0 (it) Derivati di 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro applicazione come medicamenti.
OA09136A (fr) Nouveau dérivé de la dihydro-1,4 pyridine denommé (-) {[(amino-2 éthoxy)-2 éthoxy] méthy1}-2 (dichloro-2,3 phényl)-4 éthoxycarbonyl-3 methoxycarbonyl-5 méthyl-6 dihydro-1,4 pyridine, son procédé de préparation et les compositions pharmaceutiques qui le contiennent.
IL84894A0 (en) Resolution of 1,4-dihydropyridine derivatives and optically active derivative salts of such derivatives
MC2050A1 (fr) Derives de benzopyrannols,compositions pharmaceutiques les contenant et procede de fabrication
MX9200777A (es) 4-[(2-benzotiazolil)metilamino]-alfa-[(3,4-difluorofenoxi)metil]-1-pip eridetanol.
OA09027A (fr) Procédé d'inhibition. d'un virus
PT81206A (fr) Procede pour la preparation de derives de furo<3,2-c>pyridines et de compositions pharmaceutiques les contenant
KR870005641A (ko) 고혈압 치료용 조성물
PT93450A (pt) Processo para a preparacao de novos derivados azetidinicos de acidos piridinocarboxilicos e de composicoes farmaceuticas que os contem
MA22611A1 (fr) Derives d'ammonium quaternaire de (+) et (-) 10-(1-azabicyclo(2,2,2) oct-3-yl-methyl) -10-h-pheno-thiazine, compositions pharmaceutiques les contenant et procede pour leur preparation .
PT94036A (pt) Processo para a preparacao de piridazinaminas anti-rinovirais
FR2692262B1 (fr) Nouveaux nicotinates de diacylglycerols, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2675142B1 (fr) Nouveaux derives de l'acide alpha-methylene 4-[(phenoxy) methyl] 5-thiazolacetique, leur procede de preparation et les intermediaires de ce procede et leur application a titre de fongicides.
OA09471A (fr) "Nouvelles benzothiazolinones substituées, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent".
FR2616149B1 (fr) Nouveau derive de l'acide benzo (b) thiophene - 7 carboxylique, son procede de preparation et les compositions pharmaceutiques qui le contiennent
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
ATA260486A (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes